Abstract:Abstract Epilepsy is a recurring neurological disease caused by the abnormal electrical activity in the brain. This disease has caused about 50 new cases in 100,000 populations every year with the clinical manifestations of awareness loss, bruising, and mobility abnormalities. Due to the lack understanding of the pathophysiology behind the illness, a wide variety of medications are available to treat epilepsy. Epileptogenesis is the process by which a normally functioning brain undergoes alterations leading to the development of epilepsy, involving various factors. This is related to the inflammation which is driven by cytokines like IL-1 and tumor necrosis factor-α (TNF-α) leads to neuronal hyperexcitability. Pro-inflammatory cytokines from activated microglia and astrocytes in epileptic tissue initiate an inflammatory cascade, heightening neuronal excitability and triggering epileptiform activity. The blood-brain barrier (BBB) maintains central nervous system integrity through its tight endothelial connections, but inflammation impact BBB structure and function which leads to immune cell infiltration. The mammalian target of rapamycin (mTOR) pathway’s excessive activation influences epileptogenesis, impacting neuronal excitability, and synapse formation, with genetic mutations contributing to epilepsy syndromes and the modulation of autophagy playing a role in seizure onset. The apoptotic pathway contribute to cell death through glutamate receptor-mediated excitotoxicity, involving pro-apoptotic proteins like p53 and mitochondrial dysfunction, leading to the activation of caspases and the disruption of calcium homeostasis. Ionic imbalances within neural networks contribute to the complexity of epileptic seizures, involving alterations in voltage-gated sodium and potassium channels, and the formation of diverse ion channel subtypes. Epileptogenesis triggers molecular changes in hippocampus, including altered neurogenesis and enhanced expression of neurotrophic factors and proteins. Oxidative stress leads to cellular damage, disrupted antioxidant systems, and mitochondrial dysfunction, making it a key player in epileptogenesis and potential neuroprotective interventions. Thalamocortical circuitry disruption is central to absence epilepsy, the normal circuit becomes faulty and results in characteristic brain wave patterns.

Research progress in molecular mechanisms of epileptogenesis

Insight into Drug Resistance in Status Epilepticus: Evidence from Animal Models

The Neurovascular Unit Dysfunction in the Molecular Mechanisms of Epileptogenesis and Targeted Therapy

Neuroinflammation in Epileptogenesis: from Pathophysiology to Therapeutic Strategies

Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies

Biomolecular mechanisms of epileptic seizures and epilepsy: a review

The Molecular Biology of Genetic-Based Epilepsies

Epigenetic regulation in epilepsy: A novel mechanism and therapeutic strategy for epilepsy

Advanced Molecular Mechanisms of Epilepsy

Research progress of epileptic encephalopathy

The Research Progress of New Antiepileptic Drugs

An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy

The Research Progress of the Generation Mechanism of Glioma Correlation of Epilepsy

Adult Neurogenesis in Epileptogenesis: an Update for Preclinical Finding and Potential Clinical Translation

Advances in the studies on the molecular and genetic aspects of epilepsy]

Decoding Epileptic Seizures: Exploring In Vitro Approaches to Unravel Pathophysiology and Propel Future Therapeutic Breakthroughs

Research Advances of Epilepsy on Cellular Level

[New developments in epileptogenesis and therapeutic perspectives]

Microglia in epilepsy

Research Progress of Gene Target Therapy for Refractory Epilepsy

Understanding the Role of Glia-Neuron Communication in the Pathophysiology of Epilepsy: A Review